Abstract:Background Although many people with MS (pwMS) modify their diet after diagnosis, there is still no consensus on dietary recommendations for pwMS. A number of observational studies have explored associations of diet and MS progression, but no studies have systematically reviewed the evidence. This systematic review aimed to provide an objective synthesis of the evidence for associations between diet and MS progression, including symptoms and clinical outcomes from observational studies. Methods We performed a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic database searches were performed for studies completed up to 26 July 2023 using PubMed (Medline), Web of Science, CINAHL, Embase (Ovid), and Scopus, followed by citation and reference list checking. We included studies using diet quality scores or dietary indices. Studies assessing individual foods, nutrients, or dietary supplements were excluded. We used the Newcastle-Ottawa Scale to assess the risk of bias of included studies. Results Thirty-two studies met the inclusion criteria. Of these, 20 were cross-sectional and 12 prospective. The most frequent outcomes assessed were disability ( n = 19), quality of life ( n = 12), fatigue ( n = 12), depression ( n = 9), relapse ( n = 8), anxiety ( n = 3), and magnetic resonance imaging (MRI) outcomes ( n = 4). Based on prospective studies, this review suggests that diet might be associated with quality of life and disability. There were also potential effects of higher diet quality scores on improved fatigue, disability, depression, anxiety, and MRI outcomes but more evidence is needed from prospective studies. Conclusions Observational studies show some evidence for an association between diet and MS symptoms, particularly quality of life and disability. However, the impact of diet on other MS outcomes remains inconclusive. Ultimately, our findings suggest more evidence is needed from prospective studies and well-designed tailored intervention studies to confirm associations.

Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics

The role of diet in multiple sclerosis: A review

Feeding the gut microbiome: impact on multiple sclerosis

Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review

Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence

Exploring the Therapeutic Potential: Bioactive Molecules and Dietary Interventions in Multiple Sclerosis Management

Dietary factors and pediatric multiple sclerosis: A case-control study

Effect of Diet and Dietary Patterns on the Progression of Multiple Sclerosis: A Review

Associations between diet and disease progression and symptomatology in multiple sclerosis: A systematic review of observational studies

Dietary Polyphenols, Microbiome, and Multiple Sclerosis: From Molecular Anti-Inflammatory and Neuroprotective Mechanisms to Clinical Evidence

The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank

Modulating the Gut Microbiome in Multiple Sclerosis Management: A Systematic Review of Current Interventions

Nutrition facts in multiple sclerosis

Dietary Modification Combined with Nutrition Education and Counseling for Metabolic Comorbidities in Multiple Sclerosis: Implications for Clinical Practice and Research

Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis

Effectiveness of various diet patterns among patients with multiple sclerosis

Dietary fatty acids and susceptibility to multiple sclerosis

Lifestyle-based Modifiable Risk Factors in Multiple Sclerosis: Review of Experimental and Clinical Findings.

Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions

Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives

The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis